Cassava Sciences reported $48.31M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Abbott USD 25.12B 28M Mar/2025
Amgen USD 538M 33.04B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Cassava Sciences USD 48.31M 48.26M Jun/2025
Eisai JPY 282.12M 44.7B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Geron USD 636.92M 636.28M Jun/2025
J&J USD 3.12B 0 Mar/2025
Merck USD 1.79B 0 Mar/2025
Novartis USD 793M 0 Dec/2024
Pfizer USD 5.68B 5.2B Jun/2025
Roche Holding CHF 107M 0 Jun/2024